Arvia R, Stincarelli M, Manaresi E, Gallinella G, Zakrzewska K
Microorganisms. 2024; 12(8).
PMID: 39203550
PMC: 11357344.
DOI: 10.3390/microorganisms12081708.
Kilich G, Perelygina L, Sullivan K
Immunol Rev. 2023; 322(1):113-137.
PMID: 38009321
PMC: 11844209.
DOI: 10.1111/imr.13290.
Lian J, Zhang Y, Liu L, Bai X, Liang Z, Zhao Y
Gastroenterology Res. 2016; 2(2):115-117.
PMID: 27956964
PMC: 5139828.
DOI: 10.4021/gr2009.03.1278.
Sixdorf U, Marker-Hermann E
Z Rheumatol. 2016; 75(9):878-884.
PMID: 27761646
DOI: 10.1007/s00393-016-0213-0.
Kazama I, Sasagawa N, Nakajima T
Case Rep Med. 2012; 2012:703281.
PMID: 22611409
PMC: 3348632.
DOI: 10.1155/2012/703281.
Parvovirus B19 nonstructural protein-induced damage of cellular DNA and resultant apoptosis.
Poole B, Kivovich V, Gilbert L, Naides S
Int J Med Sci. 2011; 8(2):88-96.
PMID: 21278893
PMC: 3030141.
DOI: 10.7150/ijms.8.88.
[Viral arthritides].
Marker-Hermann E, Schutz N, Bauer H
Z Rheumatol. 2010; 69(10):871-8.
PMID: 21128048
DOI: 10.1007/s00393-010-0701-6.
Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.
Kivovich V, Gilbert L, Vuento M, Naides S
Int J Med Sci. 2010; 7(3):110-9.
PMID: 20567611
PMC: 2880839.
DOI: 10.7150/ijms.7.110.
Outcome of patients with arthritis and parvovirus B19 DNA in synovial membranes.
Schmid S, Bossart W, Michel B, Bruhlmann P
Rheumatol Int. 2007; 27(8):747-51.
PMID: 17401566
DOI: 10.1007/s00296-007-0337-2.
Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.
Poole B, Zhou J, Grote A, Schiffenbauer A, Naides S
J Virol. 2006; 80(8):4114-21.
PMID: 16571827
PMC: 1440431.
DOI: 10.1128/JVI.80.8.4114-4121.2006.
Parvovirus B19-induced apoptosis of hepatocytes.
Poole B, Karetnyi Y, Naides S
J Virol. 2004; 78(14):7775-83.
PMID: 15220451
PMC: 434113.
DOI: 10.1128/JVI.78.14.7775-7783.2004.
Parvovirus B19-related chronic monoarthritis: immunohistochemical detection of virus-positive lymphocytes within the synovial tissue compartment: two reported cases.
Lennerz C, Madry H, Ehlhardt S, Venzke T, Zang K, Mehraein Y
Clin Rheumatol. 2004; 23(1):59-62.
PMID: 14749987
DOI: 10.1007/s10067-003-0800-8.
Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit?.
Severin M, Levy Y, Shoenfeld Y
Clin Rev Allergy Immunol. 2003; 25(1):41-8.
PMID: 12794260
DOI: 10.1385/CRIAI:25:1:41.
Human parvovirus B19.
Heegaard E, Brown K
Clin Microbiol Rev. 2002; 15(3):485-505.
PMID: 12097253
PMC: 118081.
DOI: 10.1128/CMR.15.3.485-505.2002.
The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.
Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann J, Drobnik W
J Virol. 2002; 76(4):2014-8.
PMID: 11799199
PMC: 135890.
DOI: 10.1128/jvi.76.4.2014-2018.2002.
Infection with Parvovirus B19.
Naides
Curr Infect Dis Rep. 2000; 1(3):273-278.
PMID: 11095799
DOI: 10.1007/s11908-999-0030-6.
Pathogenesis of human parvovirus B19 in rheumatic disease.
Kerr J
Ann Rheum Dis. 2000; 59(9):672-83.
PMID: 10976079
PMC: 1753262.
DOI: 10.1136/ard.59.9.672.
Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.
Cacoub P, Boukli N, Hausfater P, Garbarg-Chenon A, Ghillani P, Thibault V
Ann Rheum Dis. 1998; 57(7):422-4.
PMID: 9797569
PMC: 1752657.
DOI: 10.1136/ard.57.7.422.
Lymphoproliferative responses after infection with human parvovirus B19.
von Poblotzki A, Gerdes C, Reischl U, Wolf H, Modrow S
J Virol. 1996; 70(10):7327-30.
PMID: 8794392
PMC: 190798.
DOI: 10.1128/JVI.70.10.7327-7330.1996.
Parvovirus B19 infection.
Kerr J
Eur J Clin Microbiol Infect Dis. 1996; 15(1):10-29.
PMID: 8641299
DOI: 10.1007/BF01586181.